Latest News of CTLT
Catalent, Inc. (CTLT) Stock Price, News, Quote & History
Five U.S. consumer groups and two labor unions are urging the FTC to block Novo Holdings' acquisition of Catalent, citing concerns about competition in weight loss drugs and gene therapies. The $16.5 ...
Decoding Catalent Inc (CTLT): A Strategic SWOT Insight
Catalent Inc faces challenges like intense competition and regulatory changes affecting cell and gene therapies. Despite financial setbacks, the company's strengths include biologics segment growth an...
Should You Invest In Catalent, Inc. (CTLT) Right Now?
Elliott Management's top 10 stock picks include Catalent, Inc. The hedge fund, known for its activist campaigns, has seen success with a 4.7% gain in 2023....
-
Are Investors Undervaluing Catalent, Inc. (NYSE:CTLT) By 24%?
By Yahoo! Finance | 3 months agoThe intrinsic value of Catalent, Inc. is estimated using a Discounted Cash Flow model, showing it may be undervalued at a 24% discount to the current stock price. Factors like future cash flows and di...